ENTERO vs RENTOMOJO: Stock Comparison
ENTERO HEALTHCARE SOLU L is the larger company by market capitalisation. ENTERO HEALTHCARE SOLU L shows faster revenue growth and a higher net margin. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.
Metric snapshot
ENTERO leads 3; RENTOMOJO leads 0 of 4
Interactive comparison
Compare the numbers that shape the decision
Every row uses its own scale. Switch lenses to compare like with like.
Valuation lens
What price are you paying?
✓ marks the usual favourable reading; it is not a recommendation.
Key Differences
Each difference is a single, relative reading — StockeZee does not name an overall winner.
Profile
| Metric | ENTERO | RENTOMOJO |
|---|---|---|
| Sector | Consumer Services | — |
| Industry | Pharmacy Retail | — |
Price
| Metric | ENTERO | RENTOMOJO |
|---|---|---|
| Live Price | ₹1,845.2 | ₹534.45 |
| Day Change | 0.18% | 1.82% |
| Volume | 76,619 | 61.25 L |
| 52-Week High | ₹1,920 | ₹581.95 |
| 52-Week Low | ₹944 | ₹482.45 |
| Distance from 52W High | -3.9% | -8.16% |
Valuation
| Metric | ENTERO | RENTOMOJO |
|---|---|---|
| Market Cap | ₹8,029 Cr | ₹5,559 Cr |
| P/E Ratio | 63.68x | — |
| P/B Ratio | 4.73x | — |
| EPS | ₹28.73 | — |
| Book Value | ₹388.09 | — |
| Dividend Yield | 0% | 0% |
Growth
| Metric | ENTERO | RENTOMOJO |
|---|---|---|
| Revenue Growth (TTM YoY) | 42.6% | 0% |
| EPS Growth (TTM YoY) | 9.1% | 0% |
| Qtr Sales Growth | 2,230.48% | — |
| Qtr Profit Growth | 1,405.67% | — |
Profitability & Leverage
| Metric | ENTERO | RENTOMOJO |
|---|---|---|
| ROE | 8.32% | — |
| ROCE | 8.38% | — |
| Net Margin | 1.75% | 0% |
| Operating Margin | 3.55% | — |
| Debt to Equity | 0.32x | — |
Shareholding
As of Jun 2026 • change vs previous quarter| Metric | ENTERO | RENTOMOJO |
|---|---|---|
| Promoter Holding | 14.4%▼ 0.01 pp | — |
| FII Holding | 4.37%▲ 0.34 pp | — |
| DII Holding | 15.48%▼ 1.14 pp | — |
| Public Holding | 27.75%▲ 0.82 pp | — |
How to Read This Comparison
Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.
Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: ENTERO HEALTHCARE SOLU L and RENTOMOJO.
Related Comparisons
Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.